Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Quentin30


T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA guides on how AA can be converted to full approval.

Why do you think Matt would state in his most recent podcast. that the mBC...

March 25, 2023

T.ONC

RE:Average cost to bring drug candidate to market = US$2.3 Bln

 More pump Noteable... "prime" the innate/adaptive immune...

March 15, 2023

T.ONC

RE:RE:Watched the Coffey interview

Oh dear, Matt really needs a new anecdote. I'm a movie guy... really Matt...

March 8, 2023

T.ONC

Not statistically significant

It's worth remembering that the Bracelet-1 trial is not powered to...

March 8, 2023

T.ONC

Well the market clearly loved the call... look at the stock

oh dear, down again...

March 3, 2023

T.ONC

RE:RE:Pfizer 90 day period expired

They did have a deal 4-5 years ago... they're called Adlai Nortye. And...

March 3, 2023

T.ONC

Pfizer 90 day period expired

Hmmm... so that period has expired. Pfizer has seen the data evolve... no...

March 3, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The Business of Biotech interview...

Nothing like rational debate is there Azzak34. Wow. Do you throw a hissy fit...

February 15, 2023

T.ONC

RE:Hard to find, under the threaded view…strong volume & price

Given that Matt has just presented, does this mean the multi-billion buyout...

February 13, 2023

T.ONC

RE:RE:Will keep my comments on ONC, ONCY.

That's a pretty dumb idea... that's like never speaking to anyone who...

February 9, 2023

T.ONC

RE:RE:RE:No-one has access to ONCY's manufacturing process

hmmm, I don't think it's 'evident'... why do you get so sh...

February 8, 2023

T.ONC

RE:RE:Good discussion

Well first Noteable, ONCY needs to demonstrate the CPI + Pela + Pax is...

February 7, 2023

T.ONC

Good discussion

Thanks to all those engaged. It's fascinating to see that holders of this...

February 7, 2023

T.ONC

RE:I like you “ red flags, I’ll address one at a time”

Just for clarification, Aware-1 announcement by Matt was in April 2019...

February 7, 2023

T.ONC

Red Flags to Consider

Imaginations have been running rampant on this board for quite some time now....

February 6, 2023

T.ONC

AMBUSH trial

Is ONCY up to its old tricks of finding yet another cul-de-sac Phase I trial....

February 3, 2023

T.ONC

RE:RE:RE:RE:RE:RE:Merck's Keytruda to gain 3rd approval for endometrial cancer

Orphan drug status in the US can be obtained if it is provable that the...

February 3, 2023

T.ONC

RE:RE:RE:RE:Waiting...

Hi Westcoast1000. Thanks, as my landing page here, I actually have one of...

January 31, 2023

T.ONC

RE:Waiting...

You know what.. When investors were waiting to hear about results from ONCY...

January 31, 2023

T.ONC

oh dear.

ONCY takes down presentation, and changes the wording only... which elicted...

January 24, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next